TrialCNS drugs2021

Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials.

Nathaniel F Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.